Timothy Eley

4.4k citations

52 papers · 1.8k indexed · 1 hit paper · h-index 21

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Hepatology 34
- Hepatitis C virus research 34
Infectious Diseases 28
- HIV/AIDS drug development and treatment 25
- HIV/AIDS Research and Interventions 5

Co-authors: Fiona McPhee (9 shared papers)Richard Bertz (19 shared papers)David Gardiner (11 shared papers)Dennis M. Grasela (9 shared papers)C Pasquinelli (8 shared papers)Megan Wind‐Rotolo (6 shared papers)Anna Persson (5 shared papers)Anna S. Lok (4 shared papers)
Journals: Journal of Hepatology (18 papers)Antiviral Therapy (4 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Clinical Pharmacokinetics (3 papers)Open Forum Infectious Diseases (2 papers)
Partner nations: United States Germany Sweden

In The Last Decade

Timothy Eley

52 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 2012 · 454 citations

Peers

Countries citing papers authored by Timothy Eley

Since Specialization

Citations

This map shows the geographic impact of Timothy Eley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Eley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Eley more than expected).

Fields of papers citing papers by Timothy Eley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Eley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Eley. The network helps show where Timothy Eley may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy Eley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy Eley Line = papers co-authored together Timothy Eley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 New England Journal of Medicine ·Anna S. Lok, David Gardiner, Eric Lawitz, Claudia Martorell, Gregory T. Everson, Reem Ghalib, Robert Reindollar, Vinod K. Rustgi, Fiona McPhee, Megan Wind‐Rotolo, Anna Persson, Kurt Zhu, Dessislava I. Dimitrova, Timothy Eley, Tong Guo, Dennis M. Grasela, C Pasquinelli Hit paper breakdown →	2012	454
2	Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options Journal of Hepatology ·Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Hiroki Ishikawa, Hideaki Watanabe, Wenhua Hu, Timothy Eley, Fiona McPhee, Eric Hughes, Hiromitsu Kumada	2012	179
3	Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders Journal of Hepatology ·Anna S. Lok, David Gardiner, Christophe Hézode, Eric Lawitz, Marc Bourlière, Gregory T. Everson, Patrick Marcellin, M. Rodríguez‐Torres, Stanislas Pol, Lawrence Serfaty, Timothy Eley, Shu-Pang Huang, Jianling Li, Megan Wind‐Rotolo, Fei Yu, Fiona McPhee, Dennis M. Grasela, C Pasquinelli	2013	111
4	Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir And Asunaprevir Hepatology ·Fiona McPhee, Dennis Hernandez, Fei Yu, Joseph Ueland, Aaron Monikowski, Arlene Carifa, Paul Falk, Chunfu Wang, Robert A. Fridell, Timothy Eley, Nannan Zhou, David Gardiner	2013	98
5	Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects The Journal of Clinical Pharmacology ·Timothy Eley, Feng Luo, Shruti Agrawal, Ashish Sanil, James Manning, Tong Li, Anne Blackwood‐Chirchir, Richard Bertz	2009	85
6	1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3 Journal of Hepatology ·Mark Sulkowski, David Gardiner, E. Läwitz, Federico Hinestrosa, Daniel Nelson, Paul J. Thuluvath, M. Rodríguez‐Torres, Anna S. Lok, Howard Schwartz, K. Rajender Reddy, Timothy Eley, Megan Wind‐Rotolo, Shu‐Pang Huang, Min Gao, Fiona McPhee, R. Hindes, B. Symonds, C Pasquinelli, Dennis M. Grasela	2012	70
7	Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma Journal of Pharmaceutical and Biomedical Analysis ·Hao Jiang, Hamza Kandoussi, Jianing Zeng, Jian Wang, Roger Demers, Timothy Eley, Bing He, Richard C. Burrell, John A. Easter, Pathanjali Kadiyala, Janice Pursley, Laura Cojocaru, Chanda Baker, John Ryan, Anne‐Françoise Aubry, Mark E. Arnold	2015	60
8	Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women HIV Medicine ·Francesca Conradie, C. Zorrilla, D. Josipović, ME Botes, Olayemi Osiyemi, Eric Vandeloise, Timothy Eley, Michael Child, Richard Bertz, Wen Hu, Victoria Wirtz, D McGrath	2011	50
9	1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS Journal of Hepatology ·Anna S. Lok, David Gardiner, Eric Lawitz, Claudia Martorell, Greg Everson, R. Ghalib, Robert Reindollar, V. Rustgi, Fiona McPhee, Megan Wind‐Rotolo, Anja Bondke Persson, Kuang kuang Zhu, Dessislava I. Dimitrova, Timothy Eley, Tao Guo, Dennis M. Grasela, C Pasquinelli	2011	48
10	Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug–Drug Interactions Clinical Pharmacokinetics ·Timothy Eley, Τushar Garimella, Wenying Li, Richard Bertz	2015	43
11	Organic Anion Transporting Polypeptide‐Mediated Transport of, and Inhibition by, Asunaprevir, an Inhibitor of Hepatitis C Virus NS3 Protease Clinical Pharmacology & Therapeutics ·Timothy Eley, Y‐H Han, S‐P Huang, Bing He, W Li, William Bedford, M. Stonier, David Gardiner, Karen Sims, AD Rodrigues, RJ Bertz	2014	41
12	The Effect of Efavirenz on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy HIV-Negative Women Antiviral Therapy ·Heather Sevinsky, Timothy Eley, Anna Persson, Dennis M. Garner, Cynthia Yones, Richard E. Nettles, Kathryn Krantz, Richard Bertz, Jenny Zhang	2010	41
13	Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics Clinical Pharmacokinetics ·Yash Gandhi, Timothy Eley, Aberra Fura, Wenying Li, Richard Bertz, Τushar Garimella	2018	40
14	The Effect of Atazanavir/Ritonavir on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Women Antiviral Therapy ·Jenny Zhang, Ellen Chung, Cynthia Yones, Anna Persson, Lisa Mahnke, Timothy Eley, Xiaohui Xu, Richard Bertz	2010	34
15	Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects The Journal of Clinical Pharmacology ·Li Zhu, Anna Persson, Lisa Mahnke, Timothy Eley, Tong Li, Xiaohui Xu, Sangeeta Agarwala, Jeffrey Dragone, Richard Bertz	2010	32
16	Randomized, Placebo-Controlled, Single-Ascending-Dose Study of BMS-791325, a Hepatitis C Virus (HCV) NS5B Polymerase Inhibitor, in HCV Genotype 1 Infection Antimicrobial Agents and Chemotherapy ·Karen Sims, Julie A. Lemm, Timothy Eley, Menping Liu, Anna Berglind, Diane L. Sherman, Eric Lawitz, Apinya Vutikullird, Pablo Tebas, Min Gao, C Pasquinelli, Dennis M. Grasela	2014	28
17	The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor Antiviral Therapy ·Timothy Eley, Bing He, Ih Chang, Elizabeth Colston, Michael Child, William Bedford, Hamza Kandoussi, C Pasquinelli, Thomas Marbury, Richard Bertz	2014	27
18	Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C Journal of Hepatology ·Jean–Pierre Bronowicki, Vlad Ratziu, Adrián Gadano, Paul J. Thuluvath, Fernando Bessone, Claudia Martorell, Stanislas Pol, Rubén Terg, Ziad Younes, Bing He, Timothy Eley, David Cohen, Fei Yu, Dennis Hernandez, Fiona McPhee, Patricia Méndez, Eric Hughes	2014	21
19	From Bench to Humans: Formulation Development of a Poorly Water Soluble Drug to Mitigate Food Effect AAPS PharmSciTech ·Preetanshu Pandey, Rhye Hamey, Dilbir S. Bindra, Zongyun Huang, Neil Mathias, Timothy Eley, John R. Crison, Brian Yan, Robert Perrone, Chandra Vemavarapu	2014	21
20	A Review of Daclatasvir Drug–Drug Interactions Advances in Therapy ·Τushar Garimella, Xiaoli You, Reena Wang, Shu‐Pang Huang, Hamza Kandoussi, Marc Bifano, Richard Bertz, Timothy Eley	2016	21

About Timothy Eley

Timothy Eley is a scholar working on Hepatology, Infectious Diseases, Virology, Epidemiology and Genetics, having authored 52 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (34 papers), HIV/AIDS drug development and treatment (25 papers), Liver Disease Diagnosis and Treatment (19 papers), Hepatitis B Virus Studies (17 papers), HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Hepatology (1.3k citations), Infectious Diseases (704 citations), Epidemiology (1.1k citations), Virology (62 citations) and Rheumatology (151 citations). Timothy Eley has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Fiona McPhee, Richard Bertz, David Gardiner, Dennis M. Grasela, C Pasquinelli, Megan Wind‐Rotolo, Anna Persson, Anna S. Lok, Eric Lawitz and Gregory T. Everson. Their work appears in journals such as Journal of Hepatology, Antiviral Therapy, Journal of Pharmaceutical and Biomedical Analysis, Clinical Pharmacokinetics and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact